Rheumatoid arthritis

Peripheral blood transcriptomic analysis of patients with rheumatoid arthritis associated interstitial lung disease reveals: distinct molecular signature with evidence of humoral and myeloid immunity

Arthritis Res TherPublished Mechanistic study

Authors' conclusion

In this preliminary study, RA-ILD patients exhibit enhanced immune responses, metabolism and cytokine activation.

Study context

Population
Patients with RA-ILD, rheumatoid arthritis (RA) without interstitial lung disease (ILD), psoriatic arthritis (PsA) and healthy controls
Participants
11 / 10 / 23 / 7
Comparison
RA-ILD vs RA non-ILD, PsA and healthy controls
  • RA-ILDn = 11
  • RA non-ILDn = 10
  • PsAn = 23
  • Healthy controls (HC)n = 7reference
Outcome
Peripheral blood gene expression profile of RA-ILD
Methodological detailsperipheral blood RNA sequencing (RNA-seq), differential gene expression, pathway and enrichment analysis, drug repurposing analysis, comparison with public SSc-ILD RNA-seq data
  • Peripheral blood RNA-seq
  • Differential gene expression, pathway and enrichment analysis
  • Drug repurposing analysis
  • Comparison with public SSc-ILD RNA-seq data

Main finding

As reported in the abstract

Differential expression in RA-ILD
  • Enrichment in immune response pathways, metabolism, IFNα and IFNγ response in RA-ILD

Further findings

Clinical and/or radiological progressors vs non-progressors (RA-ILD subgroup)

Enriched pathways in progressors: cell cycle, DNA replication, IFNγ response, inflammasome assembly, negative regulation of immune response

Drug repurposing

ITK, Syk and FAK inhibitors are candidate compounds potentially reversing the RA-ILD progression signature

RA-ILD vs SSc-ILD

Shared pathways: metabolism, extracellular matrix, IFNγ response, response to microorganisms

Original publication

Peripheral blood transcriptomic analysis of patients with rheumatoid arthritis associated interstitial lung disease reveals: distinct molecular signature with evidence of humoral and myeloid immunity. Arthritis Res Ther. Published 6 May 2026. doi:10.1186/s13075-026-03767-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.